ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.

Objective. Endothelial cell-specific molecule 1 (ESM1) has been implicated as an oncogene in several types of cancer. However, the potential role of ESM1 in esophageal carcinogenesis (ESCA)/esophageal squamous cell carcinoma (ESCC) is still unclear. Methods. The expression, function, and survival da...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International pp. 1 - 16
Autores principales: Li, Juan, Yang, Dong, Zhang, Cong, Wei, Sisi, Zhao, Ruinian, Dai, Suli, Shan, Baoen
Formato: pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell 7/27/2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158209954&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 158209954
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 7/27/2022
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        158209954
        158209954
        158209954
        10.1155/2022/5328192
        158209954
      ppf: 1
      ppct: 15
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.
      aug:
        au:
          Li, Juan
          Yang, Dong
          Zhang, Cong
          Wei, Sisi
          Zhao, Ruinian
          Dai, Suli
          Shan, Baoen
        affil: Department of Intensive Care Unit, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011 Hebei, China
      sug:
        subj:
          Esophageal Neoplasms Prognosis
          Squamous Cell Carcinoma of Head and Neck Prognosis
          Endothelial Cells Metabolism
          Tumor Markers, Biological Metabolism
          Oncogenes
          Bioinformatics
          Human
          Reverse Transcriptase Polymerase Chain Reaction
          Fluorescent Antibody Technique
          Immunohistochemistry
          Survival Analysis
          In Vitro Studies
          Progression-Free Survival
          Univariate Statistics
          Cox Proportional Hazards Model
          Cell Line, Tumor
          Gene Expression
      ab: Objective. Endothelial cell-specific molecule 1 (ESM1) has been implicated as an oncogene in several types of cancer. However, the potential role of ESM1 in esophageal carcinogenesis (ESCA)/esophageal squamous cell carcinoma (ESCC) is still unclear. Methods. The expression, function, and survival data of ESM1 were observed using a bioinformatics approach. Subsequently, the expression level of ESM1 in surgical esophageal tumors and adjacent normal tissues was detected by qRT–PCR and immunofluorescence. We further revealed protein expression by immunohistochemistry (IHC), which is related to the prognosis of patients with ESCC using survival analysis. In vitro, knockdown of ESM1 in KYSE150 and KYSE510 cell lines, colony formation assays, wound healing assays, and Transwell assays were performed. Results. ESM1 is significantly elevated in 12 of 20 types of human cancer. ESM1 is highly expressed in tumor tissue compared with adjacent normal tissue and was identified as a hub gene in ESCA. Clinical outcome endpoints of overall survival (OS), progression-free interval (PFI), and disease-specific survival (DSS) curves showed that patients whose ESM1 expression was high had a lower clinical survival rate. The ESM1 high-expression group has a certain correlation with clinical stage and grade. The IHC of ESM1 further demonstrated that the higher the expression was, the worse the N classification and pTNM stage in patients with ESCC, which had a distinctly poorer overall 5-year survival rate. Univariate analysis showed that age, N classification, pTNM stage, and ESM1 expression were all prognostic factors, although multivariate Cox regression analysis showed that only pTNM stage was an independent prognostic factor. In vitro, silencing ESM1 suppressed the proliferation, migration, and invasion of KYSE150 and KYSE510 cells. Conclusions. ESM1 is a hub gene in the initiation and progression of ESCA/ESCC that promotes the proliferation, migration, and invasion of esophageal cancer cells and may be a promising therapeutic target and prognostic indicator.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N